EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Therapeutic Approaches and Genetic Insights in Stargardt Disease: A Comprehensive Review

Laura Andreea Ghenciu iD, Ovidiu Alin Hațegan, Emil Robert Stoicescu iD, Roxana Iacob iD, Alina Maria Șișu

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25168859 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Laura Andreea Ghenciu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Sciences, "Victor Babeș" University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, 300041 Timișoara, Romani…. Hauptthemen laut MEDLINE: Stargardt Disease, Genetic Therapy, ATP-Binding Cassette Transporters. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stargardt disease, one of the most common forms of inherited retinal diseases, affects individuals worldwide. The primary cause is mutations in the ABCA4 gene, leading to the accumulation of toxic byproducts in the retinal pigment epithelium (RPE) and subsequent photoreceptor cell degeneration. Over the past few years, research on Stargardt disease has advanced significantly, focusing on clinical and molecular genetics. Recent studies have explored various innovative therapeutic approaches, including gene therapy, stem cell therapy, and pharmacological interventions. Gene therapy has shown promise, particularly with adeno-associated viral (AAV) vectors capable of delivering the ABCA4 gene to retinal cells. However, challenges remain due to the gene’s large size. Stem cell therapy aims to replace degenerated RPE and photoreceptor cells, with several clinical trials demonstrating safety and preliminary efficacy. Pharmacological approaches focus on reducing toxic byproduct accumulation and modulating the visual cycle. Precision medicine, targeting specific genetic mutations and pathways, is becoming increasingly important. Novel techniques such as clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 offer potential for directly correcting genetic defects. This review aims to synthesize recent advancements in understanding and treating Stargardt disease. By highlighting breakthroughs in genetic therapies, stem cell treatments, and novel pharmacological strategies, it provides a comprehensive overview of emerging therapeutic options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stargardt DiseaseGenetic TherapyATP-Binding Cassette TransportersHumansMutationStem Cell TransplantationAnimalsMacular DegenerationRetinal Pigment EpitheliumCRISPR-Cas Systems

Stichwörter der Autor:innen

ABCA4 geneCRISPR/Cas9Stargardt diseasegene therapypharmacological interventionsprecision medicinestem cell therapy

Substanzen

ABCA4 protein, humanATP-Binding Cassette Transporters

Autor:innen und Institutionen

  • Department of Functional Sciences, "Victor Babeș" University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.
  • Discipline of Anatomy and Embriology, Medicine Faculty, Vasile Goldis Western University of Arad, Revolution Boulevard 94, 310025 Arad, Romania.
  • Field of Applied Engineering Sciences, Specialization Statistical Methods and Techniques in Health and Clinical Research, Faculty of Mechanics, 'Politehnica' University Timișoara, Mihai Viteazul Boulevard No. 1, 300222…
  • Department of Radiology and Medical Imaging, 'Victor Babeș' University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.
  • Research Center for Pharmaco-Toxicological Evaluations, 'Victor Babeș' University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.
  • Department of Anatomy and Embriology, 'Victor Babeș' University of Medicine and Pharmacy Timișoara, 300041 Timișoara, Romania.

ORCID-Profile: Laura Andreea Ghenciu, Emil Robert Stoicescu, Roxana Iacob

Zitieren

APA

Ghenciu, L. A., Hațegan, O. A., Stoicescu, E. R., Iacob, R., & Șișu, A. M. (2024). Emerging Therapeutic Approaches and Genetic Insights in Stargardt Disease: A Comprehensive Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168859

Vancouver

Ghenciu LA, Hațegan OA, Stoicescu ER, Iacob R, Șișu AM. Emerging Therapeutic Approaches and Genetic Insights in Stargardt Disease: A Comprehensive Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168859

BibTeX
@article{Ghenciu2024,
  author = {Ghenciu, Laura Andreea and Hațegan, Ovidiu Alin and Stoicescu, Emil Robert and Iacob, Roxana and Șișu, Alina Maria},
  title = {Emerging Therapeutic Approaches and Genetic Insights in Stargardt Disease: A Comprehensive Review},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25168859}
}
Kostenlos starten →